XML 44 R34.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stockholders' Equity (Details Textual) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Jul. 31, 2015
May. 31, 2015
Aug. 31, 2014
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Dec. 31, 2014
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                
Notes payable       $ 106,478   $ 106,478   $ 27,200
Number of Options       10,675,800   10,675,800    
Stock-based compensation expense           $ 14,500 $ 10,000  
Purchase of Company stock   $ 10,800       (10,800)    
Purchase of Company stock, shares   120,000            
Shareholder [Member]                
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                
Option granted 300,000              
Notes payable $ 75,000     $ 75,000   75,000    
Options expiration period 3 years              
Minimum [Member]                
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                
Annual sales revenue target           2,000,000    
Maximum [Member]                
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                
Annual sales revenue target           $ 100,000,000    
Performance Based Stock Options [Member]                
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                
Number of options, Granted     300,000     9,375,000    
Weighted average exercise price, Granted     $ 0.20          
Number of options, Granted value     $ 8,000          
Number of Options       300,000   300,000    
Stock-based compensation expense       $ 10,500 $ 6,500 $ 14,500 $ 10,000  
Unearned share based compensation       340,000   $ 340,000    
Stock option amortized service period     1 year          
Performance Based Stock Options [Member] | Minimum [Member]                
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                
Weighted average exercise price, Granted           $ 0.20    
Annual sales revenue target           $ 2,000,000    
Performance Based Stock Options [Member] | Maximum [Member]                
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                
Weighted average exercise price, Granted           $ 5.00    
Annual sales revenue target           $ 100,000,000    
Director [Member]                
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                
Option granted           40,800    
Notes payable       $ 10,200   $ 10,200    
Common stock issued to directors           60,000